For individuals with elevated Lp(a) levels measured in nmol/L (>125 nmol/L), screening for modifiable non-genetic factors (i.e., dietary habits, hormonal changes, chronic kidney disease, hepatic impairment, and inflammatory conditions) that may increase Lp(a) is recommended, followed by consideration of Lp(a)-lowering agents as appropriate. Here, LPA is linked to chronic kidney disease.